- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 38 | -9.52 | -9.52 | -0.03 | 0.0 | 85.0 | -0.03 | 62.5 | 88.46 | -0.08 | -60.0 | -33.33 | 0.27 | 28.57 | 200.0 | 56.83 | -10.43 | 18.94 | -5.75 | 71.16 | 94.96 | -4.20 | 33.44 | 95.31 | -0.02 | 50.0 | 81.82 | -0.01 | 0.0 | 87.5 | -4.20 | 57.49 | 95.31 | -4.20 | 33.44 | 95.31 | 19.55 | -25.00 | 44.88 |
| 24Q2 (19) | 42 | 0.0 | 0.0 | -0.03 | -50.0 | -137.5 | -0.08 | 27.27 | 0 | -0.05 | -150.0 | -138.46 | 0.21 | 10.53 | -12.5 | 63.45 | -3.51 | -1.83 | -19.94 | -4.13 | -529.74 | -6.31 | -25.2 | -144.69 | -0.04 | 0.0 | -500.0 | -0.01 | 0.0 | -133.33 | -9.88 | -96.03 | -153.06 | -6.31 | -25.2 | -144.69 | 14.64 | 19.45 | 29.26 |
| 24Q1 (18) | 42 | 0.0 | 0.0 | -0.02 | 88.89 | -140.0 | -0.11 | 31.25 | -320.0 | -0.02 | 91.67 | -140.0 | 0.19 | 18.75 | -17.39 | 65.76 | -0.38 | -6.95 | -19.15 | 54.09 | -318.36 | -5.04 | 89.03 | -152.61 | -0.04 | 42.86 | -300.0 | -0.01 | 85.71 | -150.0 | -5.04 | 89.03 | -152.61 | -5.04 | 89.03 | -152.61 | 48.27 | 49.45 | 34.86 |
| 23Q4 (17) | 42 | 0.0 | 2.44 | -0.18 | 10.0 | -146.15 | -0.16 | 38.46 | -132.0 | -0.24 | -300.0 | -128.92 | 0.16 | 77.78 | -65.22 | 66.01 | 38.15 | -6.63 | -41.71 | 63.47 | -201.71 | -45.96 | 48.65 | -234.03 | -0.07 | 36.36 | -136.84 | -0.07 | 12.5 | -143.75 | -45.96 | 48.65 | -234.03 | -45.96 | 48.65 | -234.03 | 7.64 | -170.00 | 19.23 |
| 23Q3 (16) | 42 | 0.0 | 0.0 | -0.20 | -350.0 | -143.48 | -0.26 | 0 | -181.25 | -0.06 | -146.15 | -113.64 | 0.09 | -62.5 | -78.05 | 47.78 | -26.07 | -29.27 | -114.19 | -2560.99 | -486.82 | -89.51 | -733.92 | -290.12 | -0.11 | -1200.0 | -191.67 | -0.08 | -366.67 | -142.11 | -89.51 | -580.72 | -290.12 | -89.51 | -733.92 | -290.12 | -29.07 | -145.00 | -50.00 |
| 23Q2 (15) | 42 | 0.0 | 0.0 | 0.08 | 60.0 | 0.0 | 0.00 | -100.0 | 0 | 0.13 | 160.0 | 533.33 | 0.24 | 4.35 | 0.0 | 64.63 | -8.55 | -10.98 | 4.64 | -47.09 | 393.62 | 14.12 | 47.39 | 3.44 | 0.01 | -50.0 | 0 | 0.03 | 50.0 | 0.0 | 18.62 | 94.36 | 36.41 | 14.12 | 47.39 | 3.44 | -22.82 | -13.59 | -95.00 |
| 23Q1 (14) | 42 | 2.44 | 13.51 | 0.05 | -87.18 | 141.67 | 0.05 | -90.0 | 131.25 | 0.05 | -93.98 | 141.67 | 0.23 | -50.0 | 43.75 | 70.67 | -0.04 | -9.42 | 8.77 | -78.61 | 125.2 | 9.58 | -72.06 | 134.34 | 0.02 | -89.47 | 133.33 | 0.02 | -87.5 | 140.0 | 9.58 | -72.06 | 134.34 | 9.58 | -72.06 | 134.34 | -18.90 | -51.20 | -16.88 |
| 22Q4 (13) | 41 | -2.38 | 24.24 | 0.39 | -15.22 | 182.98 | 0.50 | 56.25 | 228.21 | 0.83 | 88.64 | 157.64 | 0.46 | 12.2 | 557.14 | 70.70 | 4.66 | 0.14 | 41.01 | 38.92 | 118.16 | 34.29 | -27.17 | 115.07 | 0.19 | 58.33 | 226.67 | 0.16 | -15.79 | 206.67 | 34.29 | -27.17 | 115.07 | 34.29 | -27.17 | 115.07 | 41.52 | 229.89 | 28.12 |
| 22Q3 (12) | 42 | 0.0 | 27.27 | 0.46 | 475.0 | 355.56 | 0.32 | 0 | 300.0 | 0.44 | 1566.67 | 145.36 | 0.41 | 70.83 | 105.0 | 67.55 | -6.96 | -9.02 | 29.52 | 3040.43 | 196.13 | 47.08 | 244.91 | 253.46 | 0.12 | 0 | 300.0 | 0.19 | 533.33 | 416.67 | 47.08 | 244.91 | 253.46 | 47.08 | 244.91 | 253.46 | 60.41 | 320.83 | 50.00 |
| 22Q2 (11) | 42 | 13.51 | 27.27 | 0.08 | 166.67 | 120.51 | 0.00 | 100.0 | 100.0 | -0.03 | 75.0 | 96.2 | 0.24 | 50.0 | 118.18 | 72.60 | -6.95 | -13.64 | 0.94 | 102.7 | 100.59 | 13.65 | 148.92 | 111.65 | 0 | 100.0 | 100.0 | 0.03 | 160.0 | 123.08 | 13.65 | 148.92 | 111.65 | 13.65 | 148.92 | 111.65 | 89.28 | 120.57 | 79.48 |
| 22Q1 (10) | 37 | 12.12 | 12.12 | -0.12 | 74.47 | 70.0 | -0.16 | 58.97 | 65.96 | -0.12 | 91.67 | 70.0 | 0.16 | 128.57 | 300.0 | 78.02 | 10.51 | -6.28 | -34.80 | 84.59 | 91.94 | -27.90 | 87.74 | 91.13 | -0.06 | 60.0 | 66.67 | -0.05 | 66.67 | 61.54 | -27.90 | 87.74 | 91.13 | -27.90 | 87.74 | 91.13 | 31.78 | -43.32 | -42.39 |
| 21Q4 (9) | 33 | 0.0 | 0.0 | -0.47 | -161.11 | -683.33 | -0.39 | -143.75 | -62.5 | -1.44 | -48.45 | 14.29 | 0.07 | -65.0 | -46.15 | 70.60 | -4.92 | -17.28 | -225.83 | -635.36 | -223.77 | -227.55 | -641.69 | -1441.67 | -0.15 | -150.0 | -66.67 | -0.15 | -150.0 | -650.0 | -227.55 | -641.69 | -1441.67 | -227.55 | -641.69 | -1441.67 | 8.41 | -53.63 | -38.90 |
| 21Q3 (8) | 33 | 0.0 | 0.0 | -0.18 | 53.85 | 62.5 | -0.16 | 65.96 | 64.44 | -0.97 | -22.78 | 40.12 | 0.2 | 81.82 | 566.67 | 74.25 | -11.68 | -5.08 | -30.71 | 80.58 | 94.75 | -30.68 | 73.82 | 94.4 | -0.06 | 64.71 | 64.71 | -0.06 | 53.85 | 62.5 | -30.68 | 73.82 | 94.4 | -30.68 | 73.82 | 94.4 | 128.41 | 28.18 | 32.98 |
| 21Q2 (7) | 33 | 0.0 | 0.0 | -0.39 | 2.5 | 32.76 | -0.47 | 0.0 | 11.32 | -0.79 | -97.5 | 30.7 | 0.11 | 175.0 | 1000.0 | 84.07 | 0.98 | 33.89 | -158.14 | 63.39 | 89.76 | -117.21 | 62.73 | 91.99 | -0.17 | 5.56 | 15.0 | -0.13 | 0.0 | 31.58 | -117.21 | 62.73 | 91.99 | -117.21 | 62.73 | 91.99 | 52.88 | -282.08 | -47.91 |
| 21Q1 (6) | 33 | 0.0 | 0.0 | -0.40 | -566.67 | 27.27 | -0.47 | -95.83 | 0.0 | -0.40 | 76.19 | 27.27 | 0.04 | -69.23 | 300.0 | 83.25 | -2.46 | 33.24 | -431.94 | -519.27 | 81.91 | -314.49 | -2030.69 | 86.52 | -0.18 | -100.0 | 5.26 | -0.13 | -550.0 | 27.78 | -314.49 | -2030.69 | 86.52 | -314.49 | -2030.69 | 86.52 | 132.05 | -239.58 | -24.58 |
| 20Q4 (5) | 33 | 0.0 | 3.12 | -0.06 | 87.5 | 89.09 | -0.24 | 46.67 | 48.94 | -1.68 | -3.7 | 25.33 | 0.13 | 333.33 | 85.71 | 85.35 | 9.12 | 2.49 | -69.75 | 88.07 | 71.15 | -14.76 | 97.31 | 93.82 | -0.09 | 47.06 | 50.0 | -0.02 | 87.5 | 88.89 | -14.76 | 97.31 | 93.82 | -14.76 | 97.31 | 93.82 | - | - | 0.00 |
| 20Q3 (4) | 33 | 0.0 | 0.0 | -0.48 | 17.24 | 0.0 | -0.45 | 15.09 | 0.0 | -1.62 | -42.11 | 0.0 | 0.03 | 200.0 | 0.0 | 78.22 | 24.57 | 0.0 | -584.80 | 62.14 | 0.0 | -547.99 | 62.57 | 0.0 | -0.17 | 15.0 | 0.0 | -0.16 | 15.79 | 0.0 | -547.99 | 62.57 | 0.0 | -547.99 | 62.57 | 0.0 | - | - | 0.00 |
| 20Q2 (3) | 33 | 0.0 | 0.0 | -0.58 | -5.45 | 0.0 | -0.53 | -12.77 | 0.0 | -1.14 | -107.27 | 0.0 | 0.01 | 0.0 | 0.0 | 62.79 | 0.5 | 0.0 | -1544.82 | 35.31 | 0.0 | -1464.16 | 37.25 | 0.0 | -0.2 | -5.26 | 0.0 | -0.19 | -5.56 | 0.0 | -1464.16 | 37.25 | 0.0 | -1464.16 | 37.25 | 0.0 | - | - | 0.00 |
| 20Q1 (2) | 33 | 3.12 | 0.0 | -0.55 | 0.0 | 0.0 | -0.47 | 0.0 | 0.0 | -0.55 | 75.56 | 0.0 | 0.01 | -85.71 | 0.0 | 62.48 | -24.98 | 0.0 | -2387.96 | -887.7 | 0.0 | -2333.42 | -876.37 | 0.0 | -0.19 | -5.56 | 0.0 | -0.18 | 0.0 | 0.0 | -2333.42 | -876.37 | 0.0 | -2333.42 | -876.37 | 0.0 | - | - | 0.00 |
| 19Q4 (1) | 32 | 0.0 | 0.0 | -0.55 | 0.0 | 0.0 | -0.47 | 0.0 | 0.0 | -2.25 | 0.0 | 0.0 | 0.07 | 0.0 | 0.0 | 83.28 | 0.0 | 0.0 | -241.77 | 0.0 | 0.0 | -238.99 | 0.0 | 0.0 | -0.18 | 0.0 | 0.0 | -0.18 | 0.0 | 0.0 | -238.99 | 0.0 | 0.0 | -238.99 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 0.1 | 55.15 | 546.3 | 0.77 | 32.9 | 0.28 | N/A | 去年係外銷許可證因素 | ||
| 2024/9 | 0.06 | -48.33 | 71.95 | 0.68 | 19.26 | 0.27 | 1.64 | 去年係外銷許可證因素 | ||
| 2024/8 | 0.12 | 33.0 | 160.62 | 0.61 | 15.64 | 0.27 | 1.67 | 去年未取得外銷產品許可證照 | ||
| 2024/7 | 0.09 | 58.27 | 824.13 | 0.49 | 1.69 | 0.24 | 1.85 | 去年未取得外銷產品許可證照 | ||
| 2024/6 | 0.06 | -39.3 | 1193.7 | 0.4 | -15.44 | 0.21 | 2.34 | 去年同期因外銷許可證因素導致兩期差異 | ||
| 2024/5 | 0.09 | 55.9 | -31.1 | 0.34 | -26.92 | 0.21 | 2.34 | - | ||
| 2024/4 | 0.06 | 4.5 | -40.11 | 0.25 | -25.18 | 0.17 | 2.92 | - | ||
| 2024/3 | 0.06 | 11.29 | -40.71 | 0.19 | -18.58 | 0.19 | 2.73 | - | ||
| 2024/2 | 0.05 | -31.45 | -50.89 | 0.13 | -2.02 | 0.18 | 2.91 | 本期較去年同期減少係負壓幫浦產品-Pump出貨減少所致 | ||
| 2024/1 | 0.08 | 64.34 | 208.11 | 0.08 | 208.11 | 0.22 | 2.28 | 本期較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2023/12 | 0.05 | -53.99 | -73.65 | 0.73 | -42.78 | 0.16 | 2.96 | 較去年同期減少係負壓幫浦產品出貨減少所致 | ||
| 2023/11 | 0.1 | 571.59 | -15.74 | 0.68 | -37.82 | 0.15 | 3.15 | - | ||
| 2023/10 | 0.02 | -58.72 | -90.79 | 0.58 | -40.53 | 0.1 | 4.9 | 與主要客戶洽談訂單中 | ||
| 2023/9 | 0.04 | -21.69 | -77.05 | 0.57 | -30.44 | 0.09 | 3.88 | 與主要客戶洽談訂單中 | ||
| 2023/8 | 0.05 | 371.6 | -69.75 | 0.53 | -19.15 | 0.06 | 5.92 | 尚未取得外銷產品許可證照 | ||
| 2023/7 | 0.01 | 121.57 | -89.86 | 0.48 | -3.64 | 0.15 | 2.37 | 尚未取得外銷產品許可證照 | ||
| 2023/6 | 0.0 | -96.76 | -94.83 | 0.47 | 17.12 | 0.24 | 1.23 | 外銷產品取得國內證照前，為保守起見與國外客戶溝通，客戶同意原定之銷貨遞延至公司取證後 | ||
| 2023/5 | 0.14 | 35.51 | 40.98 | 0.47 | 47.51 | 0.34 | 0.89 | - | ||
| 2023/4 | 0.1 | 3.45 | 79.96 | 0.33 | 50.41 | 0.31 | 0.98 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2023/3 | 0.1 | -7.81 | 38.07 | 0.23 | 40.22 | 0.23 | 1.09 | - | ||
| 2023/2 | 0.11 | 330.03 | 138.13 | 0.13 | 41.87 | 0.31 | 0.81 | 本期較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2023/1 | 0.02 | -85.94 | -48.19 | 0.02 | -48.19 | 0.32 | 0.78 | - | ||
| 2022/12 | 0.18 | 47.13 | 1933.21 | 1.27 | 205.48 | 0.46 | 0.39 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2022/11 | 0.12 | -26.59 | 1455.97 | 1.1 | 168.77 | 0.44 | 0.41 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2022/10 | 0.16 | 2.86 | 217.85 | 0.98 | 144.01 | 0.48 | 0.38 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2022/9 | 0.16 | 3.19 | 122.58 | 0.81 | 133.15 | 0.41 | 0.34 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2022/8 | 0.15 | 58.01 | 63.41 | 0.66 | 135.86 | 0.34 | 0.42 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2022/7 | 0.1 | 12.83 | 203.33 | 0.5 | 172.98 | 0.28 | 0.5 | 本期及本年度累計較去年同期增加係負壓幫浦產品出貨增加所致 | ||
| 2022/6 | 0.09 | -11.68 | 76.46 | 0.4 | 166.56 | 0.24 | 0.58 | 本期較去年同期增加，係醫療器材委託開發收入增加，本年度累計營收較去年增加係負壓幫浦產品出貨增加所致 | ||
| 2022/5 | 0.1 | 72.98 | 189.67 | 0.32 | 209.43 | 0.23 | 0.62 | 本期較去年同期增加，係血栓負壓移除導管系統-負壓幫浦產品出貨增加，本年度累計營收較去年增加亦因該產品出貨增加所致 | ||
| 2022/4 | 0.06 | -20.62 | 106.24 | 0.22 | 219.09 | 0.17 | 0.81 | 本期較去年同期增加，係腦中風血栓負壓移除導管系統-負壓幫浦出貨增加，本年度累計營收較去年增加亦因該產品出貨增加所致 | ||
| 2022/3 | 0.07 | 58.99 | 290.55 | 0.16 | 293.31 | 0.16 | 0.55 | 本期較去年同期增加，係腦中風血栓負壓移除導管系統-負壓幫浦出貨增加，本年度累計營收較去年增加亦因該產品出貨增加所致 | ||
| 2022/2 | 0.04 | -6.44 | 122.98 | 0.09 | 295.47 | 0.1 | 0.89 | 本期較去年同期增加，係腦中風血栓負壓移除導管系統-負壓幫浦出貨增加，本年度累計營收較去年增加亦因該產品出貨增加所致 | ||
| 2022/1 | 0.05 | 451.44 | 1331.43 | 0.05 | 1331.43 | 0.06 | 1.4 | 本期較去年同期增加，係腦中風血栓負壓移除導管系統-負壓幫浦出貨增加，本年度累計營收較去年增加亦因該產品出貨增加所致 | ||
| 2021/12 | 0.01 | 12.59 | -85.29 | 0.42 | 130.56 | 0.07 | 1.48 | 本期較去年同期減少，係腦中風血栓負壓移除導管系統-負壓幫浦出貨減少，本年度累計營收較去年增加亦因該產品出貨增加所致 | ||
| 2021/11 | 0.01 | -85.0 | -83.45 | 0.41 | 235.03 | 0.13 | 0.77 | |||
| 2021/10 | 0.05 | -27.97 | 104.09 | 0.4 | 431.98 | 0.22 | 0.46 | 本期營收及本年度累計營收較去年增加，主係110/10委託開發服務收入及腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨增加所致 | ||
| 2021/9 | 0.07 | -24.23 | 404.52 | 0.35 | 596.64 | 0.2 | 0.46 | 主係110/09委託開發服務收入及腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/8 | 0.09 | 193.29 | 2742.59 | 0.28 | 672.11 | 0.18 | 0.51 | 主係110/08新增委託開發服務收入及腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/7 | 0.03 | -34.35 | 173.95 | 0.18 | 462.27 | 0.11 | 0.78 | 主係110/07腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/6 | 0.05 | 44.97 | 988.41 | 0.15 | 623.43 | 0.11 | 0.64 | 主係110/06腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/5 | 0.03 | 23.16 | 1316.38 | 0.1 | 523.87 | 0.08 | 0.88 | 主係110/05腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/4 | 0.03 | 50.3 | 336.52 | 0.07 | 389.91 | 0.07 | 1.07 | 主係110/04腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/3 | 0.02 | -9.22 | 232.29 | 0.04 | 432.77 | 0.04 | 1.44 | 主係110/03腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/2 | 0.02 | 500.59 | 2205.74 | 0.02 | 904.29 | 0.08 | 0.73 | 主係110/02腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期增加所致 | ||
| 2021/1 | 0.0 | -94.33 | 128.76 | 0.0 | 128.76 | 0.11 | 0.55 | 主係泡沫式人工腦膜產品出貨所致 | ||
| 2020/12 | 0.06 | 26.66 | 787.8 | 0.18 | 9.26 | 0.13 | 0.46 | 腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨成長所致 | ||
| 2020/11 | 0.05 | 84.97 | 41.93 | 0.12 | -23.29 | 0.09 | 0.7 | - | ||
| 2020/10 | 0.03 | 78.06 | -25.67 | 0.08 | -40.26 | 0.04 | 1.41 | - | ||
| 2020/9 | 0.01 | 326.88 | -68.53 | 0.05 | -45.63 | 0.03 | 2.06 | 主係109/9腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期減少所致 | ||
| 2020/8 | 0.0 | -71.73 | -69.06 | 0.04 | -23.87 | 0.02 | 3.08 | 主係109/8腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨較去年同期減少所致 | ||
| 2020/7 | 0.01 | 160.8 | 1071.0 | 0.03 | -10.64 | 0.02 | 3.23 | 主係109/7腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨量較去年同期增加所致 | ||
| 2020/6 | 0.0 | 88.65 | -21.36 | 0.02 | -41.06 | 0.01 | 4.57 | - | ||
| 2020/5 | 0.0 | -62.04 | 68.79 | 0.02 | -44.83 | 0.01 | 4.25 | 主係109/5 醫材快速原型業務出貨量較去年同期增加所致 | ||
| 2020/4 | 0.01 | 14.41 | -77.94 | 0.01 | -50.47 | 0.01 | 4.75 | 主係109/4腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨量較去年同期減少所致 | ||
| 2020/3 | 0.01 | 529.88 | 0.0 | 0.01 | 0.0 | 0.01 | 7.68 | 主係109/3醫材快速原型業務出貨量較去年同期增加所致 | ||
| 2020/2 | 0.0 | -40.41 | 0.0 | 0.0 | 0.0 | 0.01 | 6.69 | 主係109/2醫材快速原型業務出貨量較去年同期增加所致 | ||
| 2020/1 | 0.0 | -78.01 | 0.0 | 0.0 | 0.0 | 0.04 | 1.47 | 主係109/1醫材快速原型業務出貨量較去年同期增加所致 | ||
| 2019/12 | 0.01 | -79.74 | 0.0 | 0.17 | 1547.7 | 0.0 | N/A | 腦中風血栓負壓移除導管系統-負壓幫浦系統產品出貨及醫材快速原型業務成長所致 | ||
| 2019/11 | 0.03 | -3.13 | 6329.41 | 0.16 | 1481.57 | 0.0 | N/A | 主係本公司之腦中風血栓負壓移除導管系統-負壓幫浦系統產品於本月出貨所致 |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 42 | 2.44 | -0.24 | 0 | -0.39 | 0 | 0.73 | -42.52 | 64.69 | -8.87 | -19.53 | 0 | -13.91 | 0 | -0.14 | 0 | -0.09 | 0 | -0.1 | 0 |
| 2022 (9) | 41 | 24.24 | 0.83 | 0 | 0.68 | 0 | 1.27 | 202.38 | 70.99 | -7.98 | 20.00 | 0 | 26.51 | 0 | 0.25 | 0 | 0.34 | 0 | 0.34 | 0 |
| 2021 (8) | 33 | 0.0 | -1.44 | 0 | -1.47 | 0 | 0.42 | 133.33 | 77.15 | -5.42 | -136.10 | 0 | -113.84 | 0 | -0.57 | 0 | -0.47 | 0 | -0.47 | 0 |
| 2020 (7) | 33 | 3.12 | -1.68 | 0 | -1.71 | 0 | 0.18 | 5.88 | 81.57 | -5.7 | -360.22 | 0 | -306.31 | 0 | -0.65 | 0 | -0.55 | 0 | -0.55 | 0 |
| 2019 (6) | 32 | 6.67 | -2.25 | 0 | -1.92 | 0 | 0.17 | 1600.0 | 86.50 | 122.14 | -441.59 | 0 | -430.99 | 0 | -0.73 | 0 | -0.71 | 0 | -0.71 | 0 |
| 2018 (5) | 30 | 15.38 | -2.02 | 0 | -1.79 | 0 | 0.01 | -50.0 | 38.94 | 21.73 | -6764.14 | 0 | -6029.98 | 0 | -0.68 | 0 | -0.61 | 0 | -0.61 | 0 |
| 2017 (4) | 26 | 30.0 | -1.94 | 0 | -1.39 | 0 | 0.02 | 0.0 | 31.99 | -3.09 | -2820.76 | 0 | -2641.25 | 0 | -0.53 | 0 | -0.5 | 0 | -0.5 | 0 |
| 2016 (3) | 20 | 100.0 | -1.65 | 0 | -0.97 | 0 | 0.02 | 100.0 | 33.01 | -7.12 | -2330.72 | 0 | -2077.82 | 0 | -0.37 | 0 | -0.33 | 0 | -0.33 | 0 |
| 2015 (2) | 10 | 11.11 | -4.93 | 0 | -1.34 | 0 | 0.01 | 0 | 35.54 | 0 | -7527.17 | 0 | -7322.32 | 0 | -0.51 | 0 | -0.5 | 0 | -0.5 | 0 |
| 2014 (1) | 9 | 0 | 0.00 | 0 | -0.74 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -0.28 | 0 | -0.26 | 0 | -0.26 | 0 |
